This track focuses on the latest methodologies and technologies in cellular analysis, particularly through flow cytometry. Participants will explore applications in hematology and oncology, emphasizing diagnostic and therapeutic implications.

This session will delve into the role of molecular diagnostics in identifying cancer biomarkers for early detection and personalized treatment. Discussions will include innovative techniques and their impact on patient outcomes.

This track will cover recent advancements in chemotherapy and radiotherapy, including novel chemotherapeutic agents and treatment protocols. Emphasis will be placed on optimizing therapeutic efficacy while minimizing side effects.

Focusing on hematological disorders, this session will address the latest diagnostic techniques and management strategies for conditions such as leukemia and myeloproliferative diseases. The integration of clinical practice with research findings will be highlighted.

This track will explore the unique challenges faced in pediatric oncology, including diagnosis, treatment, and survivorship. Innovative approaches and research in this field will be discussed to improve outcomes for young patients.

This session will focus on the translation of laboratory research into clinical applications in oncology. Participants will examine case studies and strategies to enhance collaboration between researchers and clinicians.